119. Bimekizumab vs secukinumab - Selenium sulfide for hyperkeratosis - Do kids with UP need epipens? - Meyerson phenomenon - Head-and-neck LCH

Release Date:

Bimekizumab vs secukinumab -
Selenium sulfide for hyperkeratosis -
Do kids with UP need epipens? -
Meyerson phenomenon -
Head-and-neck LCH -
Want to donate to the cause? Do so here! http://www.uofuhealth.org/dermasphere
Check out our video content on YouTube: https://www.youtube.com/@dermaspherepodcast
and VuMedi!: https://www.vumedi.com/channel/dermasphere/
The University of Utah's Dermatology ECHO: ⁠⁠https://physicians.utah.edu/echo/dermatology-primarycare -
⁠⁠Connect with us!
- Web: ⁠https://dermaspherepodcast.com/⁠
- Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: https://www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle’s other podcast, SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠
Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:
- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)
- ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn more dermatology!)

119. Bimekizumab vs secukinumab - Selenium sulfide for hyperkeratosis - Do kids with UP need epipens? - Meyerson phenomenon - Head-and-neck LCH

Title
119. Bimekizumab vs secukinumab - Selenium sulfide for hyperkeratosis - Do kids with UP need epipens? - Meyerson phenomenon - Head-and-neck LCH
Copyright
Release Date

flashback